APONTIS PHARMA AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.73 EUR | -3.22% |
|
+6.68% | +84.19% |
| Apr. 05 | Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications | MT |
| Mar. 28 | Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 682B | ||||||
| 586B | ||||||
| 364B | ||||||
| 327B | ||||||
| 285B |
